AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, aerosol valves, and digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

AptarGroup Inc.

Goldman Sachs analyst maintained a Hold rating on Yamato Holdings Co today and set a price target of Yen1,900.00. Yamato Holdings Co has an analyst...

Goldman Sachs Sticks to Its Hold Rating for Yamato Holdings Co (YATRF)

Yatra Online Limited ( ($IN:YATRA) ) has issued an announcement. Yatra Online Limited has issued an updated investor presentation for the quarter a...

Yatra Online Corrects Investor Presentation Metrics for FY26 Results

An announcement from Yatra Online Limited ( ($IN:YATRA) ) is now available. Yatra Online Limited announced that it has published the audited financ...

Yatra Online Publishes Audited FY26 Results in Leading Dailies

The latest update is out from Yatra Online Limited ( ($IN:YATRA) ). Yatra Online Limited reported its most profitable year ever for the financial y...

Yatra Online Delivers Record FY26 Profit Despite Macro Headwinds

Yatra Online Limited ( ($IN:YATRA) ) has provided an update. Yatra Online Limited’s board has approved the audited standalone and consolidated fina...

Yatra Online Clears FY26 Audit With Clean Opinion Amid IPO Funds Queries

An announcement from Atlanta Braves Holdings Inc Class A ( ($BATRA) ) is now available. At its 2026 Annual Meeting of Stockholders held on May 20, ...

Atlanta Braves Shareholders Elect Director, Ratify Auditor

In a report released today, Stephen Volkmann from Jefferies maintained a Buy rating on Caterpillar, with a price target of $1,045.00. According to ...

Caterpillar (CAT) Gets a Buy from Jefferies

Atrys Health SA ( ($ES:ATRY) ) just unveiled an announcement. Atrys Health reported first-quarter 2026 revenue of 37.5 million euros, up 6.3% year-...

Atrys boosts profitability, slashes debt and expands oncology footprint in Q1 2026

Atrys Health SA ( ($ES:ATRY) ) just unveiled an update. Atrys Health posted first-quarter 2026 revenue of 37.5 million euros, up 6.3% year on year,...

Atrys Health Boosts Q1 Profitability and Slashes Debt as International Oncology Business Accelerates

Atrys Health SA ( ($ES:ATRY) ) just unveiled an announcement. Atrys Health SA reported solid first-quarter 2026 results, with revenue up 6.3% and E...

Atrys Health Lifts Q1 2026 Earnings, Cuts Debt and Deepens Oncology Focus

In a report released today, Ian Gillies from Stifel Nicolaus maintained a Buy rating on AtkinsRealis, with a price target of C$99.00. According to ...

Stifel Nicolaus Sticks to Its Buy Rating for AtkinsRealis (SNCAF)

Astronics (($ATRO)) has held its Q1 earnings call. Read on for the main highlights of the call. Astronics’ latest earnings call struck an upbeat to...

Astronics Earnings Call Signals Growth Amid Debt

AptarGroup, Inc. (($ATR)) has held its Q1 earnings call. Read on for the main highlights of the call. AptarGroup’s latest earnings call painted a c...

AptarGroup Balances Profit Pressures With Pharma Momentum

The latest update is out from Atricure ( ($ATRC) ). At its May 18, 2026 annual meeting, AtriCure shareholders approved an amendment to the 2023 Sto...

AtriCure Shareholders Approve Expanded Equity and Governance Plans

In a report released today, from Canaccord Genuity reiterated a Buy rating on Water Intelligence, with a price target of p515.00. The word on The S...

Canaccord Genuity Reaffirms Their Buy Rating on Water Intelligence (WATR)

In a report released yesterday, Sabahat Khan from RBC Capital maintained a Buy rating on AtkinsRealis, with a price target of C$120.00. Khan covers...

RBC Capital Keeps Their Buy Rating on AtkinsRealis (SNCAF)

RBC Capital analyst Arthur Nagorny maintained a Buy rating on Mattr yesterday and set a price target of C$13.00. According to TipRanks, Nagorny is ...

Mattr (MATR) Gets a Buy from RBC Capital

It can be difficult given the sheer number and wide range of Wall Street analysts to easily filter out who are the best performers. However, TipRan...

Here are Our 3 Best Wall Street Analysts in the Last Month

Stifel Nicolaus analyst Ian Gillies maintained a Hold rating on Mattr today and set a price target of C$8.75. According to TipRanks, Gillies is a 5...

Stifel Nicolaus Remains a Hold on Mattr (MATR)

Yamato Holdings Co ( ($JP:9064) ) has provided an update. Yamato Holdings will transfer its 70% stake in consolidated subsidiary Yamato Credit & Fi...

Yamato Sells Credit Subsidiary to Nojima Unit, Books One-Off Loss to Strengthen Balance Sheet

There’s a lot to be optimistic about in the Industrial Goods sector as 3 analysts just weighed in on BETA Technologies, Inc. Class A (BETA), Astron...

Analysts Are Bullish on Top Industrial Goods Stocks: BETA Technologies, Inc. Class A (BETA), Astronics (ATRO)

Atlanta Braves Holdings Inc Class A (($BATRA)) has held its Q1 earnings call. Read on for the main highlights of the call. Atlanta Braves Holdings ...

Atlanta Braves Holdings Bets Big on Braves Vision

Analysts are intrested in these 5 stocks: ( ($HUBS) ), ( ($ATRA) ), ( ($UPWK) ), ( ($FSLY) ) and ( ($PLNT) ). Here is a breakdown of their recent


HubSpot, Atara, Upwork, Fastly, Planet Fitness Trending With Analysts

RBC Capital analyst Sabahat Khan maintained a Buy rating on AtkinsRealis yesterday and set a price target of C$120.00. Khan covers the Industrials ...

RBC Capital Remains a Buy on AtkinsRealis (SNCAF)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Atara Biotherapeutics (ATRA), Artivion (AORT) and ...

Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA), Artivion (AORT) and Rocket Pharmaceuticals (RCKT)

Traders will find all of the latest earnings, analysts, and economic news in our daily wrap-up.


Morning News Wrap-Up, 5/7/26: Today’s Biggest Stock Market Stories!

In a report released today, Rick Wise from Stifel Nicolaus maintained a Buy rating on Atricure, with a price target of $50.00. Wise covers the Heal...

Stifel Nicolaus Sticks to Its Buy Rating for Atricure (ATRC)

In a report released today, Marie Thibault from BTIG reiterated a Buy rating on Atricure, with a price target of $45.00. Thibault covers the Health...

BTIG Reaffirms Their Buy Rating on Atricure (ATRC)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alphatec Holdings (ATEC), Atricure (ATRC) and Tempus AI, Inc. Cla...

Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC), Atricure (ATRC) and Tempus AI, Inc. Class A (TEM)

In a report released on May 1, Sabahat Khan from RBC Capital maintained a Hold rating on Caterpillar, with a price target of $877.00. The company’s...

RBC Capital Reaffirms Their Hold Rating on Caterpillar (CAT)

Atara Biotherapeutics ( ($ATRA) ) has issued an announcement. On April 30, 2026, Atara Biotherapeutics received notice from Nasdaq that it no longe...

Atara Biotherapeutics Receives Nasdaq Non-Compliance Delisting Notice

In a report released today, Stephen Volkmann from Jefferies maintained a Buy rating on Caterpillar, with a price target of $1,045.00. Volkmann cove...

Jefferies Sticks to Their Buy Rating for Caterpillar (CAT)

Barclays analyst Adam Seiden maintained a Hold rating on Caterpillar today and set a price target of $800.00. According to TipRanks, Seiden is a 5-...

Caterpillar (CAT) Gets a Hold from Barclays

Analysts have been eager to weigh in on the Healthcare sector with new ratings on AptarGroup (ATR) and Viridian Therapeutics (VRDN). AptarGroup (AT...

Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR) and Viridian Therapeutics (VRDN)

The latest announcement is out from Astron Limited ( ($AU:ATR) ). Astron Limited reported a net operating cash outflow of A$1.1 million for the Mar...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ATR	$116.38	+0.13%	344.52K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ATR	$116.38	+0.1%	344.52K
3
4
5
6

ATR

ATR

Get AptarGroup Inc. Data in Excel

Get AptarGroup Inc. Data in Excel